[1] |
Ziaee M,Azarkar G.Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic(East of Iran) in 2012[J].Hepat Mon,2013,13(8):e11168. |
[2] |
Liaw YF,Chu CM.Hepatitis B virus infection[J].Lancet,2009,37(63):582-592. |
[3] |
Ocama P,Opio CK,Lee WM.Hepatitis B virus infection:current status[J].Am J Med,2005,118(12):1413. |
[4] |
Kosaka K,Hiraga N,Imamura M,et al.A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections[J].Biochem Biophys Res Commun,2013(13):1712-1719. |
[5] |
McMahon BJ.Epidemiology and natural history of hepatitis B[J].Semin Liver Dis,2005,25(Suppl 1):3-8. |
[6] |
Yuen MF,Tanaka Y,Fong DY,et al.Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B[J].J Hepatol,2009,15(10):80-88. |
[7] |
El-Serag HB,Rudolph KL.Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J].Gastroenterology,2007,13(7):2557-2576. |
[8] |
章晓联.病毒免疫学[M].北京:科学出版社,2010:165-172. |
[9] |
中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南2010年更新版[J].中华实验和临床感染病杂志,2011,5(1):70-100. |
[10] |
中华医学会传染病与寄生虫病学分会,中华医学会肝病分会.病毒性肝炎防治方案[J].传染病信息,2000,13(4):141-150. |
[11] |
曹雪涛.免疫学技术及其应用[M].北京:科学出版社,2010:3-4. |
[12] |
杨炼,管小琴,陈显兵.HBV感染对人体T细胞免疫功能影响的研究[J].重庆医科大学学报,2005,30(4):552-555. |
[13] |
叶国强,朱美玲.HBV感染者外周血T淋巴细胞亚群分析[J].中华综合医学杂志,2004,6(2):8-9. |
[14] |
Vassilopoulos D,Rapti I,Nikolaou M,et al.Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B[J].J Viral Hepat,2008,15(11):817-826. |